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Abstract:  Biotransformation of bis-bibenzyl perrottetin F (1), isolated from the liverwort Lunularia cruciata by 
Aspergillus niger, has been investigated. New metabolites (2-4) have been isolated using reversed phase 
semipreparative HPLC and their structures were established to be 8-hydroxyperrottetin F, C-7-C-8 cleaved 
product, and perrottetin F 6’-sulfate using 1D and 2D NMR, HR-ESI-MS, IR and UV spectroscopy. The 
antimicrobial and cytotoxic properties of these compounds were also evaluated. Given the suggested cytotoxic 
properties of the parent compound, antiproliferative activity against healthy human lung fibroblasts (MRC5) and 
human lung carcinoma (A549) of three metabolites were evaluated revealing their lower cytotoxic properties in 
comparison to the starting compound - perrottetin F. The antimicrobial properties of these compounds were also 
evaluated, with the inhibitory activity against the Pseudomonas aeruginosa PAO1 and Staphylococcus aureus 
determined between 100 µM and 450 µM. The metabolites showed remarkable ability to inhibit synthesis of 
bacterial quorum-sensing signal molecules such as short chain acyl homoserine lactones (AHLs). Therefore, 
biotransformation method represents fast and effective tool for obtaining new bioactive structures. 
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The Marchantiophyta (liverworts) produce various aromatic compounds among them bis-
bibenzyls, such marchantin, riccardin and perrottetin series which are very specific and rare natural 
products found only in this division. Up to date, 103 cyclic and acyclic bis-bibenzyls have been 
isolated from the liverworts [1-5]. Bis-bibenzyl skeleton comprises four aromatic rings (A-D), 
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biosynthesized from dimerization of lunularic acid trough dihydrocoumaric acid and prelunularin [5]. 
Perrottetin F (1) has been found in the thalloid liverworts Radula perrottetii, R. kojana and Lunularia 
cruciata [4,6]. This acyclic bis-bibenzyl was obtained as the major component from the methanol 
extract of L. cruciata [7]. Bis-bibenzyls possess wide range of biological activities such as 
cytotoxicity, 5- lipoxygenase and NO production inhibitory activity, antitumor, farnesoid X receptor 
(FXR)-activating activity, antimicrobial and many others [8,9]. Anti-influenza PA endonuclease 
potential of perrottetin F is described previously [10]. 
Known as ‘green technology’, biotransformation is used for converting various compounds 
into derivatives with possible biological activities [11]. Microbiological transformation of natural 
compounds can be useful for pharmaceutical drug development, in order to obtain more active 
compounds or to increase the yields of the pharmaceutical active components. It is an important 
strategy in the structural modification of natural compounds by using microorganisms, animal tissues 
or enzymes with great potential to produce novel, more efficient compounds [12]. Compounds 
obtained by biotransformation may improve properties in comparison to the starting component. It 
may also be good alternative to chemical synthesis of new drugs [13]. Literature data mainly show 
biotransformation of phytosterols, steroids, terpenes, alkaloids, and flavonoids [14]. It was noted that 
bacteria made complete steroid structure degradation while, micromycetes were active in multiple 
steroid hydroxylations. Some diterpenes (stemodin, stemodinone and stemarin) were biotransformed 
by A. niger to give three hydroxylated compounds [15]. Sesquiterpene cinnamodial was 
biotransformed to lactonized products [16].  
In this study, an easy and cheap method for obtaining bioactive bis-bibenzyl derivatives using 
micromycete A. niger is presented. As per authors best knowledge there is only one report on 
biotransformation of bis-bibenzyl [9] and this is the first investigation on perrottetin F (1) 
biotransformation, from which three new derivatives were obtained, and their biological activities 
were investigated. 
 
2. Materials and Methods 
2.1. General Experimental Procedures 
Optical rotations were measured on a Rudolph Research Analytical Autopol IV automatic 
polarimeter with methanol as solvent and concentration of compounds 1.00 mg/mL. UV spectra were 
recorded on a GBC Cintra UV/VIS spectrometer with methanol as solvent in concentration range 3-9 
× 10-5 M. IR spectra were obtained on a Thermoscientific Nicolet 6700 FT-IR spectrometer. NMR 
spectra were measured on a Bruker Avance III 500 spectrometer at 500.26 MHz for 1H and 125.80 
MHz for 13C, with CD3OD as a solvent. HR-ESI-MS data were obtained on Agilent 6210 Time-of-
Flight LC/MS system equipped with an ESI interface (ESITOFMS). Solvent was methanol, mobile 
phase was: 0.2% HCOOH/CH3CN 1:1, 0.2 mL/min. The ESI was operated in a negative mode and 
nitrogen was used as the drying gas (12 L/min) and nebulizing gas at 350 °C (45 psi). The OCT RF 
voltage was set to 250 V and the capillary voltage was set to 4.0 kV. The voltages applied to the 
fragmentor and skimmer were 140 V and 60 V, respectively. Scanning was performed from 100 to 
1500 m/z (mass-to-charge ratio). For column chromatography (CC) silica gel 60 (SiO2; 0.063 – 0.200 
mm, Merck) was used. Analytical TLC was carried out on silica gel 60 GF254 20 × 20 cm plates, with 
a layer thickness of 0.25 mm (Merck). Preparative TLC was carried out on silica gel 60 GF254 (SiO2; 
<0.063 mm, Merck) packed 20 × 20 cm plates, thickness 0.75 mm. Semipreparative HPLC separation 
was performed on an Agilent Instrument 1100 series equipped with a DAD (Agilent Technologies, 
G1315C). The column used was a Zorbax Eclipse XDB C18 (9.4 mm × 250 mm, 5 μm). Solvents for 
HPLC separation were of chromatographic grade. Solvents for CC were freshly distilled. 
 
 
2.2. Plant material, Extraction and Isolation 
A voucher specimen (No. 17290) has been deposited in the Herbarium at the Institute of 
Botany and Botanical Garden “Jevremovac”, University of Belgrade (BEOU). Extraction and 
Bukvicki et.al., Rec. Nat. Prod. (2021) 15:4 281-292 
 
283 
fractionization of crude methanol extract of liverwort Lunularia cruciata (L.) Dumort. ex Lindb. 
(Lunulariaceae) by silica gel CC and isolation of dominant compound perrottetin F have been done 
according to previously described procedure [7]. 
 
2.3. Aspergillus niger TBUYN-2 Growth and Biotransformation Procedure 
Micromycete Aspergillus niger TBUYN-2 obtained from the soil collected in Osaka 
prefecture [9] was grown in Czapek-peptone medium (pH 7) in incubator shaker at 120 rpm, 25 oC for 
3 days. When mycromicete achieved full growth, perrottetin F (1) (50 mg was dissolved in 0.5 mL of 
ethanol) was added into three flasks (150 mg in total) and left in thermoshaker at 120 rpm, 25 oC for 4 
days. EtOH (0.5 mL) was added in the flask with A. niger and medium, as control. 
After 4 days, medium and mycelia were separated in a Buchner separation funnel. For 
extraction of compounds from media EtOAc was used, while mycelia were left in acetone for next 7 
days. pH of media was 3.5. To get basic-neutral fraction (BNF) from media and mycelia (pH 9) 50% 
Na2CO3 was added. Acidic fraction (AF) (pH 2-3) was obtained by adding 5% H2SO4 solution in 
media. After extraction analytical TLC was carried out on aluminium silica sheet gel 60F254 
(MERCK). Chromatograms were developed using CH2Cl2: EtOH (7:1 v/v) as the developing solvent. 
The presence of biotransformed compounds were detected under UV light (254 nm) and spraying the 
30% H2SO4 solution on TLC sheet. The biotransformation products were separated using semi-
preparative HPLC. 
 
2.4. Cytotoxicity Assay 
Cytotoxicity of compounds (1-4) was measured using the methods described previously [17]. 
A549 (human lung carcinoma, obtained from ATCC) and MRC5 cells (human lung fibroblast, 
obtained from ATCC) were plated in a 96-well flat-bottom plate at a concentration of 1×104 cells per 
well, grown in humidified atmosphere of 95% air and 5% CO2  at 37 °C, and maintained as monolayer 
cultures in RPMI-1640 medium supplemented with 100 µg/mL streptomycin, 100 U/mL penicillin, 
and 10% (v/v) fetal bovine serum (FBS). After 24 h of A549 and MRC5 cells incubation, the media 
containing increasing concentrations of each tested compound (with the highest concentration tested 
being 500 µM) were added to the cells. Stock solutions of bis-bibenzyls were prepared in DMSO (50 
mM). Control cultures received the solvent DMSO and blank wells contained 200 µL of growth 
medium. After 48 h of incubation, cells proliferation was determined using 3-(4,5-dimethylthiazol-2-
yl)-2,5-diphenyltetrazolium bromide (MTT) reduction assay. MTT solution (0.5 mg/mL) was added 
after treatment and incubated for 1 h, followed by dimethyl sulfoxide incubation. Cell proliferation 
was determined from the absorbance (A) at 540 nm on Tecan Infinite 200 Pro multiplate reader (Tecan 
Group, Männedorf, Switzerland). The MTT assay was performed two times in quadruplicate and the 
results were presented as percentage of the control (untreated cells) that was arbitrarily set to 100%. 
The cell viability rate (%) was calculated as follows: (A of the treated group/A control group) × 100. 
 
2.5. Antibacterial Activity Assays 
 
Pseudomonas aeruginosa PAO1 ATCC 27853, Staphylococcus aureus ATCC 25923 and S. 
marcescens ATCC 27117 used in this study were from the American Type Culture Collection 
(ATCC). P. aeruginosa PAOJP2, P. aeruginosa PA14-R3, and PAO1ΔpqsAmini-CTXlux-PpqsA 
were kindly provided by Dr. Livia Leoni, Department of Biology, Roma Tre University, Italy. 
Chromobacterium violaceum CV026 [18] was provided by Prof. Vittorio Venturi (ICGB, Trieste, 
Italy). Bacteria were routinely grown in Luria-Bertani (LB) medium (1% (w/v) NaCl, 1% (w/v) 
Tryptone, 0.5% (w/v) yeast extract) with or without agar (1.5% w/v) with shaking (180 rpm) at 37 °C. 
Tryptone soy broth (TSB) (Oxoid) was used for growth of P. aeruginosa PAO1 in the assay of biofilm 
formation. Antibiotics kanamycin (Kanamycin sulfate from Streptomyces kanamyceticus, BioReagent, 
Sigma-Aldrich, purity >95%), streptomycin (Streptomycin sulfate salt, BioReagent, Sigma-Aldrich, 
purity >96%) and tetracycline (BioReagent, Sigma-Aldrich, purity >96%) were incorporated into 
growth medium at the concentration of 30 µg/mL or 200 µg/mL in the case of kanamycin, 20 µg/mL 
for streptomycin and 100 µg/mL for tetracycline.  




2.5.1. Minimum Inhibitory Concentration (MIC) Determination  
 
The minimum inhibitory concentrations of bis-bibenzyls were determined according to standard 
broth microdilution assays recommended by the Clinical and Laboratory Standards Institute (M07- 
A9). Stock solutions of bis-bibenzyls were prepared in DMSO (50 mM). The highest tested 
concentration of each compound was 500 µM. The inoculums were 105 colony forming units 
(CFU)/mL. The MIC value corresponds to the lowest concentration that inhibited the growth after 24 h 
at 37 °C. 
 
2.5.2. Inhibition of P. aeruginosa PAO1 Biofilm Formation 
 
P. aeruginosa biofilms were grown in TSB medium without shaking conditions. The effect of 
perrottetin F (1) and biotransformants on biofilm forming ability was tested at concentrations of 50% 
of determined MIC (0.5MIC) for each compound, on polystyrene flat-bottomed microtitre 96 well 
plates as previously described with modifications [19]. Briefly, overnight culture of P. aeruginosa was 
diluted in a fresh LB medium to optical density of OD600 nm=0.2 and 100 µL of the diluted culture 
with appropriate compound at the concentration of 0.5 MIC was added to the plate. After incubation 
for 24 h at 37 °C, the plate was washed twice with sterile water, dried, stained for 30 min with 0.1 % 
crystal violet in order to determine biofilm formed. Stained cells were washed with sterile water to 
remove unbound crystal violet. After drying, 150 µL of 30% (v/v) acetic acid was added to solubilize 
the dye. After 10 min, the content of the wells was homogenized, and the OD of samples were 
measured at 550 nm using microplate reader Infinite 200PRO (Tecan). The experiment was done in 
quintuplicate and repeated two times. 
 
2.5.3. Activity on Bacterial Pigment Production 
 
Effect of bis-bibenzyls on violacein synthesis was evaluated with Chromobacterium 
violaceum CV026 indicator strain, as reported previously [18, 20]. Briefly, semisolid LB agar (0.3%, 
w/v; 5mL) was seeded with 50 μL of an overnight culture of C. violaceum CV026 supplemented by N-
hexanoyl- L-homoserine lactone (Sigma) to a final concentration of 5 μM and poured over the surface 
of LB agar plates. When the overlaid agar had solidified, sterilized discs containing 250 μg of each 
compound were placed on the plates. Petri dishes were incubated in the upright position overnight (30 
°C) and examined for violacein synthesis. Inhibition of violacein synthesis was defined by the 
presence of white haloes in a purple background. 
Overnight culture of S. marcescens was diluted 100-fold in molten semi-solid LB agar (0.3 % 
w/v) and poured over solid LB medium. Cellulose discs containing compounds (250 μg/disc) were 
placed on solidified agar and incubated for 24 h at 30 °C. Inhibition of prodigiosin synthesis was 
identified by the absence of red colour around the disc. 
 
2.5.4. Activity on Acyl Homoserine Lactones (AHLs) and Alkyl Quinolones (AHQs) Production using 
Biosensors 
 
For the detection and quantification of long-chain (3OC12-HSL) and short-chain AHLs (C4-
HSL) in AHLs production assays with two P. aeruginosa biosensors based on luminescent bacteria: P. 
aeruginosa PA14-R3ΔlasIPrsaI::lux and P. aeruginosa PAO1 ΔrhlIpKD-rhlA sensors for monitoring 
C12-AHL and C4-AHL are used, respectively [21, 22]. 
P. aeruginosa PA14-R3Δ lasIPrsaI:lux and P. aeruginosa PAO1 ΔrhlIpKD-rhlA biosensors 
reporter strains were grown overnight at 37 °C on LA agar plate. Plate for P. aeruginosa PAO1 
ΔrhlIpKD-rhlA was supplemented with kanamycin (Sigma), 200 μg/mL. Bacterial colonies were 
resuspended in LB medium with or without appropriate antibiotic and overnight cultures of the 
biosensors  were diluted to OD600=0.045 in LB. Bacterial suspension consists of 100 μL of P. 
aeruginosa PA14-R3ΔlasIPrsaI::lux sensor supplemented by 3OC12-HSL lactone (Sigma) to a final 
concentration of 5 μM or the suspension consists of 100 μL of P. aeruginosa PAO1 ΔrhlIpKD-rhlA 
sensor supplemented by C4-HSL (Sigma), to a final concentration of 5 μM, were dispensed in black, 
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clear-bottom 96-well microtiter plates. Microtiter plates were incubated at 37 °C with shaking, after 4 
h of incubation OD600 and bioluminescence were simultaneously measured on Tecan Infinite 200 Pro 
multiplate reader (Tecan Group Ltd., Männedorf, Switzerland). Luminescence values was normalized 
by the cell density and expressed as percentage of the corresponding untreated control values. All 
experiments were performed in triplicate at least three times.  
For detection and quantification of quorum sensing molecules 2-alkyl-4-quinolones (AHQs), 
such as 2-heptyl -3-hydroxy-4 quinolone (PQS) and 2-heptyl-4-quinolone (HHQ), a lux-based P. 
aeruginosa AHQ sensor was employed in liquid microtiter plate assay. 100 µl of P. aeruginosa PAO1 
ΔpqsAmini-CTXluxPpqsA biosensor supplemented by HHQ lactone (Sigma), to a final concentration 
of 5 μM, was used for detection and quantification of AHQs molecules as described previously [23]. 
 
Compound 2: brown, amorphous solid; [α]D22 +16.0 (c 1.0, MeOH); UV (MeOH) λmax (log ε) 212 
(4.54), 275 (3.76); IR (KBr) νmax 3413, 2923, 2855, 1600, 1506, 1456, 1352, 1342, 1322, 1257, 1215, 
1168, 1033, 964, 853, 785 cm–1; 1H NMR and 13C NMR, see Table 1; HR-ESI-MS m/z 457.1668 [M – 
H]– (calcd for C28H25O6 – H, 457.1651). 
 
Compound 3: brown, amorphous solid; UV (MeOH) λmax (log ε) 224 (3.56), 275 sh (4.32); IR (KBr) 
νmax 3452, 2924, 2854, 1632, 1507, 1454, 1384, 1213, 1166, 1123, 1083, 1034, 792, 686 cm–1; 1H 
NMR and 13C NMR, see Table 1; HR-ESI-MS m/z 351.1244 [M – H]– (calcd for C21H20O5 – H, 
351.1233). 
 
Compound 4: white, amorphous solid; UV (MeOH) λmax (log ε) 215 (4.85), 272 (4.13), 282 (4.11); IR 
(KBr) νmax 3413, 2925, 2857, 1595, 1590, 1505, 1455, 1281, 1242, 1215, 1166, 1060, 1021, 999, 856, 
780, 729, 695 cm–1; 1H NMR and 13C NMR, see Table 1; HR-ESI-MS m/z 521.1283 [M – H]– (calcd 
for C28H26O8S – H, 521.1270). 
 
 
3. Results and Discussion  
 
3.1. Isolation and Identification of A. niger Biotransformed Products of Perrottetin F 
From the EtOAc extract of basic-neutral fraction of the A. niger medium, after separation on 
reversed-phased semipreparative HPLC compounds 2 and 3 have been isolated. From the acetone 
extract of the mycelium, compounds 2 and 4 have been isolated. 
Compound 2 was obtained as a brown amorphous substance. Molecular ion [M – H]- at m/z 
457.1668 of its HR-ESI-MS spectrum and the 13C NMR spectrum (Table 1, Figures S7, S10 and S11, 
Supporting Information) were in accordance with molecular formula C28H26O6. The UV absorption 
bands at 212 and 275 nm and the IR bands at 3413 and 1600 cm-1 indicated the presence of phenol 
moieties in 2. In the 1H NMR spectrum signals of the A-, C-, and D-rings were very similar to those of 
perrottetin F (1) (Figures S1 and S8, Supporting Information). However, the signals of the B-ring 
protons (connected by the COSY spectrum, Figure S12, Supplementary Material) were downfield 
shifted. Оne proton signal appeared at δH, 4.60 (t, 7.0 Hz) and there were six “bridge” protons (δH 2.5-
2.9 region, Table 1) when compared with 1. These data and the HSQC spectrum (Figure S15, 
Supporting Information), indicated the presence of a hydroxyl group at one of the four benzyl 
positions. Strong NOE correlations of the proton at δH 4.60 with H-10 and H-14, as well as weaker 
NOE correlations with H-3 and H-5 (Figure S14, Supporting Information) revealed that OH was at C-
8. The COSY correlations H-8/H-7a, H-7b and the HMBC correlations H-10, H-14/C-8 gave 
additional confirmation (Figure S13 and S18, Supporting Information). Thus, the structure of the first 
new bis-bibenzyl 2 was established as 8-hydroxyperrottetin F. Its absolute configuration remained to 
be clarified. 
Compound 3 was isolated as a brown amorphous substance. Its molecular [M – H]- ion at m/z 
351.1244 from the HR-ESI-MS and 13C NMR spectrum (Figures S19 and S22, Supporting 
Information) revealed the molecular formula C21H20O5, i.e. seven C atoms less compared with 
compound 1. The UV absorption bands at 224 and 275 nm and the IR bands at 3452 and 1632 cm-1 
indicated the presence of phenol moieties in 3. The 1D and 2D NMR data revealed the presence of 
New bioactive bis-bibenzyl derivatives 
 
286 
three benzene rings with the hydroxyl group at one benzyl position. The singlet at δH 4.45 (δC 65.0) 
originated from the methylene group, suggested terminal hydroxyl substituent. The HMBC 
correlations of this singlet with the overlapped signals of C-3 and C-5 and NOE correlations H-3, H-
5/H-7 (Figures S27 and S24, Supporting Information) referred to the 7-hydroxyl derivative. The rest of 
1H and 13C NMR signals, very similar to those of the compounds 1 and 2, were ascribed to the C and 
D rings atoms (Figures S1, S8, S23-S25, Supporting Information). Thus, the structure of compound 3 













Table 1. 1H and 13C NMR Data of Compounds 2-4 recorded in CD3OD (500 MHz for 1H and 125 MHz for 13C) 
 
Position 
2 3 4 
δC δH δC δH δC δH 
1 157.8 - 158.9 - 157.5 - 
2 118.2 6.61 d (8.5) 118.3 6.74 d (8.5) 118.3 6.75 d (8.5) 
3 131.7 6.90 d (8.5) 129.7 7.17 d (8.5) 130.7 7.07 d (8.5) 
4 134.0 - 136.7 - 137.3 - 
5 131.7 6.90 d (8.5) 129.7 7.17 d (8.5) 130.7 7.07 d (8.5) 
6 118.2 6.61 d (8.5) 118.3 6.74 d (8.5) 118.3 6.75 d (8.5) 
7 46.0 2.80 m 65.0 4.45 s 38.3 2.83 m 
8 76.7 4.60 t (7.0) - - 39.3 2.80 m 
9 147.5 - - - 144.8 - 
10 114.2 6.63 t (2.0) - - 116.5 6.62 t (2.0) 
11 158.4 - - - 158.5 - 
12 115.2 6.52 dd (7.5; 2.0) - - 113.9 6.59 m 
13 130.3 6.96 t (7.5) - - 130.4 7.05 t (8.0) 
14 118.7 6.61 mb - - 121.0 6.64 m 
1' 136.1 - 136.4 - 140.9 - 
2' 145.6 - 145.3 - 142.6 - 
3' 112.7 5.97 d (2.0) 113.0 6.03 d (2.0) 118.9 6.43 d (2.0) 
4' 134.3 - 134.4 - 134.1 - 
5' 112.4 6.33 d (2.0) 112.8 6.38 d (2.0) 119.5 7.05 d (2.0) 
6' 147.8 - 148.0 - 146.2 - 
7' 38.4 2.56 m 38.5 2.60 m 38.3 2.75 m 
8' 39.1 2.56 m 39.2 2.60 m 39.0 2.75 m 
9' 144.6 - 144.6 - 144.4 - 
10' 116.5 6.40 t (2.0) 116.6 6.47 dd (8.0; 2.0)c 116.6 6.55 t (2.0) 
11' 158.3 - 158.4 - 158.4 - 
12' 113.8 6.43 d (8.0) 113.9 6.43 t (2.0) 113.9 6.57 dd (7.5; 1.0) 
13' 130.2 6.89 t (8.0) 130.3 6.92 t (7.5) 130.4 7.02 t (8.0) 
14' 121.0 6.43 dd (8.0; 2.0) 121.0 6.47 dd (8.0; 2.0)c 121.0 6.60 m 
a J values are given in parenthesis 
b signals overlayed with signals for H-2 and H-6 
c signals overlayed 
 
For compound 4, obtained as a white amorphous substance, two molecular formulas 
C28H26O8S and C28H26O10 were possible regarding the molecular ion [M – H]- at m/z 521.1283 from the 
HR-ESI-MS spectrum and the 13C NMR spectrum (Figures S28 and S30, Supporting Information). 
Calculating isotopic distribution and percentage of the [M+2-H]- ion from the HR-ESI-MS spectrum, 
our experimental value of 9.1% was close to the theoretical value of 10.9% for the [M+2-H]- ion for 
the molecular formula C28H26O8S. In the case of C28H26O10, [M+2-H]- ion prediction was 6.7%. NMR 
analyses revealed great similarity of 1H NMR spectrum of 4 to those of its biotransformation parent 
compound perrottetin F (1). The 1H NMR spectrum of 4 was almost identical to that of perrottetin F 
(1) (Figures S29 and S1, Supporting Information), except the H-3' and H-5' signals of 4 that were 
downfield shifted (for 0.3 and 0.6 ppm, respectively), in comparison to compound 1. This indicated 
another substituent at C-6' position, since multiplicity of both, H-3' and H-5', remained the same (two 
doublets with J=2.0 Hz). The difference of chemical shifts of C-ring carbons between 4 and perrottetin 
F (especially C-3', C-5', but also C-1', C-2' and C-6') additionally confirmed significant change in C-
ring (Figures S30 and S3, Supporting Information). Having in mind the presence of sulphur in 4, ie. 
the molecular formula C28H26O8S, it was concluded that sulfate group was at C-6' position instead of 
OH group present in perrottetin F (1). All 2D NMR correlations confirmed the structure of perrottetin 
F-6'-sulfate (4) (Figures S31-S36, Supporting Information). 
 Although this is the first time that biotransformation of perrottetin F (1) was investigated, the 
obtained compounds are in agreement with literature data for the similar compounds obtained by the 
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microbial biotrasformation using A. niger. The “target” positions in molecules during A. niger action 
were mostly allylic or benzyl C-atoms, or double bonds [24]. Successful biotransformation of thymol 
at the benzyl position by A. niger was reported [25]. In this work, compound 2 was obtained by 
hydroxylation at benzyl position C-8, and 3 by oxidative cleavage at the benzyl position C-7. 
Additionally, sulfate derivatives after Aspergillus spp. biotransformation were previously reported [26] 
and are in accordance with our findings (compound 4). 
 
3.2. Biological Activity Evaluations of Three Biotransformation Products in Comparison to Perrottetin 
F (1)  
The cytotoxic activity (antiproliferative effect) of biotransformants was evaluated against two cell 
lines and compared to perrottetin F (1) (Table 2). Compounds (2-4) obtained by biotransformation of 
perrottetin F were less effective in inhibiting the growth of human lung carcinoma (A549) as well as 
human healthy lung fibroblasts (MRC5) in comparison to the parent compound. The reduction was 
between 1.6- to 16.6-fold for A549 and 2.3- to 8.3-fold for MRC5 cells, with the 4 being the least and 
2 being the most active amongst biotransformants (Table 2). Some literature data proved that present 
of sulfated groups may reduce cytotoxic potential of molecule [27]. For example, flavonoids luteolin 
and hispidulin showed higher cytotoxicity on melanoma cells line (B16F10) compared with luteolin-7-
sulphate and hispidulin 7-sulphate [27]. This can be reason of slightly lower activity of compound 4 in 
regard to perrottetin F. 
Biotransformed product 2 also showed the slight increase in the selectivity toward cancer in 
comparison to healthy cell line compared to perrottetin F. 
 
Table 2. The cytotoxicity (IC50, µM) and antibacterial properties (MIC, µM) of three 
biotransformation products in comparison to perrottetin F 
 IC50 (µM) MIC (µM) 
 A549 MRC5 S. aureus P. aeruginosa PAO1 
Perrottetin F (1) 15a 30 100 150 
2 25 70 450 200 
3 50 80 400 250 
4 250 250 400 250 
aThe results are expressed as means calculated from three independent experiments with standard deviation 
between 1-3%. 
 
Next, we focused on antibacterial potential of perrottetin F (1) and its three biotransformed 
products against two common nosocomial opportunistic pathogens: S. aureus and P. aeruginosa PAO1 
(Table 2). Very weak antibacterial activities against S. aureus and P. aeruginosa PAO1 with minimal 
inhibitory concentrations (MICs) ranging from 100 µM for perrottetin F to 450 µM for 2 were 
recorded. Again, the activity of biotransformants was 1.3- to 4.5-fold reduced in comparison to the 
parent compound (Table 2).  
The effect of compounds (2-4) on bacterial pigment production was assessed using C. 
violaceum CV026 and S. marcesens (Figure S37, Supporting Information). C. violaceum CV026 is 
white, violacein negative, and has no constitutive ability of violacein pigment production, but CV026 
can sense exogenously added AHLs and responds by producing purple violacein [18]. In this assay, 
the tested compounds demonstrated only weak antagonistic activity on violacein production in C. 
violaceum CV026 when 250 µg of test compound was applied per disc. Inhibition of violacein 
production with 2 and 3 was visible as a slightly brighter area around the discs (Figure S37A, 
Supporting Information). The interference of perrottetin F and biotransformants with pigment 
production in S. marcescens was examined by assessing modulation of prodigiosin production in a 
disc assay (Figure S37B, Supporting Information). It was obvious from the obtained results that 
compounds did not trigger inhibition of prodigiosin synthesis, however, added compounds could 
change the color of the halo around the discs, from red to pink. The pink zones were larger in the 
presence of biotransformats than in the presence of parent compound perrottetin F (1) (Figure S37B, 
Supporting Information). Taken together, obtained results with C. violaceum CV026 and S. marcesens 
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suggested that perrottetin F as well as three metabolites (2-4) had moderate effect on violacein and 
prodigiosin production under tested conditions. 
S. marcescens has N-acylhomoserine lactones (AHLs)- dependent QS system and produces at 
least four AHLs (3-oxo-C6-HSL, C6-HSL, C7-HSL, and C8-HSL), which regulate production of 
prodigiosin and phenotypic characteristics such as motility and biofilm formation that have been 
connected to virulence of this strain [28]. On the other side, P. aeruginosa also possesses four QS 
systems: two acyl-homoserine lactone (AHL)-mediated QS systems, one 2-alkyl-4-quinolones 
(AHQs)-mediated QS system and the IQS-dependent QS system. Three autoinducer synthases LasI, 
RhlI, and PqsABCDH produce autoinducers 3-oxo-C12-homoserine lactone (HSL), C4-HSL, and 2-
heptyl-3-hydroxy-4-quinolone, respectively. To evaluate the potential of the perrottetin F (1) and 
biotransformed products 2-4 modulators of specific QS pathway in P. aeruginosa, three mutant 
biosensors strains dependent on exogenous AHLs were used: P. aeruginosa PA14-R3ΔlasIPrsaI::lux, 
used to determine 3OC12-HSL production (LasI activity), P. aeruginosa PAO1 ΔrhlIpKD-rhlA, used 
for C4-HSL production (RhlI activity), and P. aeruginosa PAO1 ΔpqsA mini-CTX luxPpqsA, used 
for assessment of PQS production (PqsABCDH activity).  
 
Figure 2. Effect of perrottetin F and compounds 2-4 (100 μM) on acyl homoserine lactone (AHL) and 
AHQs production in P. aeruginosa. The P. aeruginosa PA14- R3ΔlasIPrsaI : lux strain was used to 
directly measure the levels of 3OC12- HSL and P. aeruginosa PAO1 ΔrhlIpKD-rhlA reporter strain 
was used to directly measure the levels of C4-HSL. Detection of AHQs (PQS and HHQ) was 
performed by the biosensor P. aeruginosa PAO1 ΔpqsA mini-CTX luxPpqsA. Biosensors grown in 
the presence of DMSO served as the 100% luminescence control ( ); - perrottetin F (1), - 2, - 3, 
- 4 
 
Obtained data (Figure 2) suggest that perrottetin F and biotransformants reduced emitted 
bioluminescence in biosensor strains, in a range of 10% to 90% compared to negative control 
(DMSO). All these compounds exerted the most potent effects on C4-HSL (Rhl activity), moderate 
effects on AHQs production (PqsABCDH activity) and weak effects on 3OC12-HSL production (Las 
activity). Biotransformed products, especially 2 and 3, had more pronounced effect in comparison to 
parent perrottetin F. Compounds 2 and 3 significantly reduced the bioluminescence in P. aeruginosa 
PAO1 ΔrhlIpKD-rhlA negatively for 95% and 90 %, respectively, in comparison to DMSO control 
(Figure 2). Also, these compounds significantly reduced the bioluminescence in P. aeruginosa PAO1 
ΔpqsAmini-CTX luxPpqsA for 60% and 35%, respectively, and in addition, reduced bioluminescence 
in P. aeruginosa PA14-R3ΔlasIPrsaI::lux, for 16% and 12% respectively. Perrottetin F (1) and 
compound 4 inhibited the bioluminescence in P. aeruginosa PAO1 ΔrhlIpKD-rhlA for 80%, and 
negatively affected the bioluminescence in P. aeruginosa PAO1 ΔpqsAmini-CTX luxPpqsA for 50% 
and 30%, respectively, while these compounds had no effect on the bioluminescence in P. aeruginosa 
PA14-R3ΔlasIPrsaI::lux. 
Taken together, these results suggested that the tested compounds, that showed no significant 
effect on the growth of P. aeruginosa and S. aureus (Table 2), were able to successfully modulate the 
production of signaling molecules that are part of the bacterial QS system (Figure 2).  
According to literature data, acyclic bis-bibenzl, perrottetin F (1) and cyclic bis-bibenzyls, 
marchantins A, B, and D showed cytotoxicity against KB cells (3.7–20 μM), DNA polymerase β 
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inhibitory (ID50 14.4–97.5 μM), and anti-HIV-1 (5.30–23.7 μg/mL) activity [29]. Perrotetin F 
exhibited very strong nitric oxide (NO) production inhibitory activity, in culture media, on RWA 
264.7 cells [4]. Perrottetin F also inhibited influenza PA (subunit of RNA polymerase) endonuclease 
activity at 10 µM [4, 8]. Perrottetin E, bis-bibenzyl isolated from Radula perrottetii inhibited KB cells 
at a concentration of 12.5 µg/mL [4].  
A series of bis-bibenzyls, including riccardin-, marchantin- and isoplagiochin-class structures 
were evaluated for anti-MRSA activity against two strains of S. aureus MRSA [30]. The structure–
activity relationships and the results of molecular dynamics simulations showed that bis-bibenzyls 
with potent anti-MRSA activity commonly have a 4-hydroxyl group at the D-benzene ring and a 2-
hydroxyl group at the C-benzene ring in the hydrophilic part of the molecule, and an unsubstituted 
phenoxyphenyl group in the hydrophobic part of the molecule containing the A–B-benzene rings. It 
was found previously that the number of hydroxyl groups on the riccardin framework is important for 
anti-MRSA activity, thus, bis-bibenzyls derivative with hydroxyl group did not show apparent anti-
MRSA activity, whereas bis-bibenzyls with two or three phenolic hydroxyl groups showed anti-
MRSA activity. Also, it was shown that riccardin-class bis(bibenzyl)-type cyclic phenolic compounds 
exhibit potent antibacterial activity towards MRSA S. aureus, comparable to that of vancomycin and 
linezolid [30]. Cyclic bis-bibenzyl, marchantin A from many Marchantia species, showed antibacterial 
activity against Bacillus cereus (MIC 12.5 µg/mL), B. megaterium (25 µg/mL), B. subtilis (25 µg/mL), 
Cryptococcus neoformans (12.5 µg/mL), Escherichia coli, Pseudomonas aeruginosa and 
Staphylococcus aureus (3.13-25 µg/mL) [4].  
AHL-mediated systems regulate the expression of many virulence factors, including LasA 
protease, phospholipase, exotoxin A, pyocyanin, rhamnolipids, elastase, and also regulate biofilms 
development. Pseudomonas aeruginosa PAO1 are known to produces a diverse 2-alkyl-4-quinolones 
(AHQs) which act as QS signal molecules and are involved in the regulation of many virulence 
factors. In the quinolone-dependent QS system, PqsABCDE and PqsH are involved in the synthesis of 
2-heptyl-4-quinolone (HHQ) and 2-heptyl-3-hydroxy-4-quinolone (PQS) [23]. Both HHQ and PQS 
can bind to the transcriptional regulator MvfR and form a complex to regulate gene expression. P. 
aeruginosa PQS and HHQ regulate the production of pyocyanin, rhamnolipids, elastase and influence 
a biofilm formation [28]. The production of diverse AHQ, which act as QS signal molecules and are 
also involved in the regulation of many virulence factors in P. aeruginosa PAO1 (i.e. elastase, 
pyocyanin, rhamnolipids, biofilm development).  
Biotransformation of bis-bibenzyls has not yet been investigated. Biotransformed products of 
these molecules found in the most thalloid liverworts could be useful in the study of antimicrobial, 
anticancer and other biologically active compounds. The microbial transformation is safe, cheap and 
constitutes an environmentally very friendly method which could be a starting platform for the 
synthesis of new pharmacological drugs. In the present research, three new bis-bibenzyl derivatives 
are obtained through biotransformation of perrottetin F by A. niger and their cytotoxic and 
antimicrobial properties were tested. Moreover, biotransformants showed an extraordinary ability to 
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